查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1813307

男性生育力追踪市场预测（至 2032 年）：按产品、使用案例、分销管道、技术、最终用户和地区进行的全球分析

Male Fertility Tracking Market Forecasts to 2032 - Global Analysis By Product, Use Case, Distribution Channel, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球男性生育追踪市场预计在 2025 年达到 44.8 亿美元，预计到 2032 年将达到 69.7 亿美元，预测期内的复合年增长率为 6.51%。

男性生育力追踪是指监测和分析影响男性生育力的各种生物、生活方式和健康因素的过程。它包括追踪精子数量、活力、形态、睪固酮水平、阴囊温度以及饮食、运动、睡眠和压力管理等生活习惯等参数。先进的数位工具、穿戴式装置和行动应用程式正越来越多地被用于提供即时洞察和预测分析。透过识别生育模式、潜在问题和最佳受孕时机，男性生育力追踪可以帮助夫妻实现生育目标，同时帮助男性保持生殖健康并发现潜在疾病的早期征兆。

男性不孕症盛行率不断上升

精子健康状况的下降和人们意识的不断增强，正在推动人们致力于更早的诊断。行动应用程式和家用套件等数位工具正在成为实验室检测的便捷替代方案。人工智慧驱动的精液分析正在提高诊断准确性和使用者体验。与更广泛的生育治疗途径的整合正在改善护理的连续性。这些趋势使市场成为积极生殖健康的关键动力。

临床怀疑和与护理途径的有限整合

对准确性和标准化的担忧阻碍了医生的采用。与电子医疗系统缺乏相容性，降低了临床效用。缺乏团队合作的护理路径削弱了后续治疗和与护理的连结。围绕数位医疗工具的监管不确定性减缓了医疗机构的采用。这些问题持续限制着临床部署。

提高社会意识，减少耻辱感

教育倡议和媒体报道正在促进围绕生殖健康的公开对话。年轻用户更容易接受数位健康工具。科技公司与医疗保健提供者之间的合作正在建立信誉和影响力。社交平臺正在提升认知度和参与度。这些转变正在为市场扩张创造动力。

报销和共同支付分散

诊断试剂套件和数位平台通常被排除在标准医疗给付之外。成本敏感的用户可能会出于经济考量而推迟或避免检测。男性生殖健康的公共资金仍然有限。报销政策的地区差异加剧了医疗服务的可近性差异。这些资金限制对包容性市场成长构成了风险。

COVID-19的影响：

新冠疫情严重影响了男性生育追踪市场，扰乱了供应链，推迟了产品发布，并限制了面对面咨询。关闭诊所和保持社交距离的措施减少了前往生育诊所的机会，延缓了相关技术的普及。然而，随着生殖健康意识的增强以及对数位平台的日益偏好，对生育追踪应用程式和家用解决方案的需求也随之增长。向远端医疗服务和远端监控工具的转变加速了技术创新，儘管初期市场面临挑战，但仍蕴藏着长期机会。

家用精液分析套件市场预计将成为预测期内最大的市场

由于对谨慎易用的诊断工具的需求不断增长，预计家用精液分析套件领域将在预测期内占据最大的市场份额。这些套件无需就诊即可即时洞察精子参数。与行动应用程式的整合增强了追踪和参与度。电子商务的普及正在扩大消费者的取得管道。对隐私和价格承受能力的偏好正在推动其普及。预计该领域将在男性不孕症治疗领域保持主导地位。

预计生育诊所和 IVF 中心部门在预测期内将见证最高的复合年增长率。

由于辅助生殖技术中数位追踪工具的日益整合，预计生育诊所和试管婴儿中心细分市场将在预测期内实现最高成长率。诊所正在采用互联诊断技术来个人化治疗并提高效率。对数据主导的生育治疗的需求正在推动对智慧技术的投资。设备製造商和临床网路之间的伙伴关係正在增强互通性。试管婴儿服务和男性因素诊断的成长正在加速其应用。预计该细分市场将在全球生育生态系统中迅速扩张。

比最大的地区

在预测期内，北美预计将占据最大的市场份额，这得益于人们对生殖健康的认识不断提高、数位健康工具的普及以及先进的医疗基础设施。美国和加拿大等国家对家用生育套件、基于智慧型手机的分析仪和连网型设备的接受度正在不断提高。支持性医疗政策和生育诊所的积极参与正在推动这些设备的普及。生活方式相关的不孕症问题的影响以及远端医疗平台的高渗透率进一步增强了该地区的市场前景。

复合年增长率最高的地区：

受文化变迁、医疗保健数位化不断提高以及对计划生育日益重视的推动，预计亚太地区在预测期内将呈现最高的复合年增长率。中国、印度、日本、韩国和澳洲等国家正在越来越多地采用价格实惠的生育追踪设备和行动应用程式。该地区的特点是不断进行宣传宣传活动和政府支持生殖健康的倡议。快速的都市化、不断增长的可支配收入以及智慧型手机的广泛使用，正在显着促进市场成长，使亚太地区成为充满活力的技术创新中心。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球男性生育能力追踪市场（按产品）

  • 家用精液检测套组
  • 基于智慧型手机的精液分析仪
  • 连网家庭分析仪
  • 荷尔蒙检测套组
  • 阴囊温度感测器
  • 男性生育能力追踪应用程式
  • 配件和耗材
  • 其他产品

6. 全球男性生育能力追踪市场（按使用案例）

  • 怀孕前筛检
  • 不孕不育的诊断与监测
  • 输精管结扎后检查
  • 治疗监测
  • 优化生活方式和健康

7. 全球男性生育能力追踪市场（依通路）

  • 在线的
  • 线下零售
  • 临床采购

8. 全球男性生育追踪市场（按技术）

  • 横向流动
  • 微流体
  • 智慧型手机中的光学成像和电脑视觉
  • 电化学生物感测器
  • 基于AI/ML的分析

9. 全球男性生育能力追踪市场（依最终用户）

  • 个人
  • 生育诊所和试管婴儿中心
  • 泌尿系统
  • 远端医疗提供者
  • 研究与学术
  • 其他最终用户

第十章全球男性生育能力追踪市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Legacy
  • Trak Fertility
  • Ro
  • Hims & Hers Health
  • EverlyWell
  • LetsGetChecked
  • Ferring Pharmaceuticals
  • Merck KGaA
  • Bayer AG
  • Sun Pharmaceutical Industries Ltd.
  • ExSeed Health
  • Yo Home Sperm Test
  • Dadi
  • SpermCheck
  • Andros Diagnostics
Product Code: SMRC30769

According to Stratistics MRC, the Global Male Fertility Tracking Market is accounted for $4.48 billion in 2025 and is expected to reach $6.97 billion by 2032 growing at a CAGR of 6.51% during the forecast period. Male fertility tracking refers to the process of monitoring and analyzing various biological, lifestyle, and health factors that influence male reproductive potential. It involves tracking parameters such as sperm count, motility, morphology, testosterone levels, scrotal temperature, and lifestyle habits like diet, exercise, sleep, and stress management. Advanced digital tools, wearables, and mobile applications are increasingly used to provide real-time insights and predictive analytics. By identifying fertility patterns, potential issues, and optimal timing for conception, male fertility tracking supports couples in achieving pregnancy goals, while also helping men maintain reproductive health and detect early signs of underlying medical conditions.

Market Dynamics:

Driver:

Rising prevalence of male-factor infertility

Declining sperm health and heightened awareness are encouraging earlier diagnostic engagement. Digital tools such as mobile apps and at-home kits are emerging as accessible alternatives to lab-based testing. AI-powered semen analysis is improving diagnostic precision and user experience. Integration with broader fertility care pathways is enhancing continuity of care. These trends are positioning the market as a key enabler of proactive reproductive health.

Restraint:

Clinical skepticism and limited integration with care pathways

Concerns about accuracy and standardization hinder physician endorsement. Lack of compatibility with electronic health systems reduces clinical utility. Disjointed care pathways weaken the link between tracking and treatment. Regulatory uncertainty around digital health tools slows institutional uptake. These issues continue to restrict clinical deployment.

Opportunity:

Greater public awareness and reduced stigma

Educational initiatives and media coverage are fostering open dialogue around reproductive health. Younger users are more receptive to digital wellness tools. Collaborations between tech firms and healthcare providers are enhancing credibility and reach. Social platforms are amplifying visibility and engagement. These shifts are creating momentum for market expansion.

Threat:

Fragmented reimbursement and out-of-pocket cost burden

Diagnostic kits and digital platforms are often excluded from standard health benefits. Cost-sensitive users may delay or avoid testing due to affordability concerns. Public funding for male reproductive health remains limited. Regional disparities in reimbursement policies exacerbate access gaps. These financial constraints pose risks to inclusive market growth.

Covid-19 Impact:

The Covid-19 pandemic significantly influenced the Male Fertility Tracking Market by disrupting supply chains, delaying product launches, and limiting in-person medical consultations. Lockdowns and social distancing measures reduced access to fertility clinics, slowing adoption of related technologies. However, increased awareness of reproductive health and the growing preference for digital platforms boosted demand for fertility tracking apps and home-based solutions. The shift toward telehealth services and remote monitoring tools accelerated innovation, fostering long-term opportunities despite initial market challenges.

The at-home semen analysis kits segment is expected to be the largest during the forecast period

The at-home semen analysis kits segment is expected to account for the largest market share during the forecast period due to rising demand for discreet and user-friendly diagnostics. These kits provide real-time insights into sperm parameters without clinical visits. Integration with mobile apps enhances tracking and engagement. E-commerce availability is expanding consumer access. Preference for privacy and affordability is driving adoption. This segment will remain dominant in male fertility tracking.

The fertility clinics & IVF centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the fertility clinics & IVF centers segment is predicted to witness the highest growth rate owing to increased integration of digital tracking tools in assisted reproduction. Clinics are adopting connected diagnostics to personalize treatment and improve efficiency. Demand for data-driven fertility care is prompting investment in smart technologies. Partnerships between device makers and clinical networks are enhancing interoperability. Growth in IVF services and male-factor diagnoses is accelerating adoption. This segment is set for rapid expansion across global fertility care ecosystems.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share by rising awareness about reproductive health, growing adoption of digital health tools, and the presence of advanced healthcare infrastructure. Countries like the United States and Canada are witnessing increasing acceptance of at-home fertility kits, smartphone-based analyzers, and connected devices. Supportive healthcare policies and active participation of fertility clinics enhance adoption. The influence of lifestyle-related fertility issues and high penetration of telehealth platforms further strengthens the market outlook in this region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fuelled by a combination of cultural shifts, increasing healthcare digitalization, and rising focus on family planning. Countries such as China, India, Japan, South Korea, and Australia are witnessing a growing adoption of affordable fertility tracking devices and mobile applications. The region is characterized by heightened awareness campaigns and government initiatives supporting reproductive health. Rapid urbanization, rising disposable incomes, and greater smartphone penetration contribute significantly to market growth, making Asia Pacific a dynamic hub for innovation.

Key players in the market

Some of the key players in Male Fertility Tracking Market include Legacy, Trak Fertility, Ro, Hims & Hers Health, EverlyWell, LetsGetChecked, Ferring Pharmaceuticals, Merck KGaA, Bayer AG, Sun Pharmaceutical Industries Ltd., ExSeed Health, Yo Home Sperm Test, Dadi, SpermCheck and Andros Diagnostics.

Key Developments:

In March 2025, Trak Fertility expanded its clinical outreach by partnering with Labcorp to integrate Trak's at-home sperm testing data into Labcorp's digital health ecosystem. This collaboration enhances continuity of care by linking Trak's consumer diagnostics with physician-ordered fertility evaluations and treatment pathways.

In October 2024, Legacy partnered with Posterity Health to deliver integrated male fertility care through a hybrid model combining at-home sperm testing and virtual specialist consultations. The collaboration expands access to semen analysis, DNA fragmentation testing, and hormone care, streamlining diagnostics and treatment for men nationwide.

Products Covered:

  • At-home semen analysis kits
  • Smartphone-based semen analyzers
  • Connected home analyzers
  • Hormone test kits
  • Scrotal temperature sensors
  • Male fertility tracking apps
  • Accessories & consumables
  • Other Products

Use Cases Covered:

  • Pre-conception screening
  • Infertility diagnosis & monitoring
  • Post-vasectomy confirmation
  • Treatment monitoring
  • Lifestyle & wellness optimization

Distribution Channels Covered:

  • Online
  • Offline retail
  • Clinical procurement

Technologies Covered:

  • Lateral flow
  • Microfluidics
  • Smartphone optical imaging & computer vision
  • Electrochemical biosensors
  • AI/ML-based analytics

End Users Covered:

  • Individuals
  • Fertility clinics & IVF centers
  • Urology
  • Telehealth providers
  • Research & academia
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Male Fertility Tracking Market, By Product

  • 5.1 Introduction
  • 5.2 At-home semen analysis kits
  • 5.3 Smartphone-based semen analyzers
  • 5.4 Connected home analyzers
  • 5.5 Hormone test kits
  • 5.6 Scrotal temperature sensors
  • 5.7 Male fertility tracking apps
  • 5.8 Accessories & consumables
  • 5.9 Other Products

6 Global Male Fertility Tracking Market, By Use Case

  • 6.1 Introduction
  • 6.2 Pre-conception screening
  • 6.3 Infertility diagnosis & monitoring
  • 6.4 Post-vasectomy confirmation
  • 6.5 Treatment monitoring
  • 6.6 Lifestyle & wellness optimization

7 Global Male Fertility Tracking Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online
  • 7.3 Offline retail
  • 7.4 Clinical procurement

8 Global Male Fertility Tracking Market, By Technology

  • 8.1 Introduction
  • 8.2 Lateral flow
  • 8.3 Microfluidics
  • 8.4 Smartphone optical imaging & computer vision
  • 8.5 Electrochemical biosensors
  • 8.6 AI/ML-based analytics

9 Global Male Fertility Tracking Market, By End User

  • 9.1 Introduction
  • 9.2 Individuals
  • 9.3 Fertility clinics & IVF centers
  • 9.4 Urology
  • 9.5 Telehealth providers
  • 9.6 Research & academia
  • 9.7 Other End Users

10 Global Male Fertility Tracking Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Legacy
  • 12.2 Trak Fertility
  • 12.3 Ro
  • 12.4 Hims & Hers Health
  • 12.5 EverlyWell
  • 12.6 LetsGetChecked
  • 12.7 Ferring Pharmaceuticals
  • 12.8 Merck KGaA
  • 12.9 Bayer AG
  • 12.10 Sun Pharmaceutical Industries Ltd.
  • 12.11 ExSeed Health
  • 12.12 Yo Home Sperm Test
  • 12.13 Dadi
  • 12.14 SpermCheck
  • 12.15 Andros Diagnostics

List of Tables

  • Table 1 Global Male Fertility Tracking Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Male Fertility Tracking Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Male Fertility Tracking Market Outlook, By At-home semen analysis kits (2024-2032) ($MN)
  • Table 4 Global Male Fertility Tracking Market Outlook, By Smartphone-based semen analyzers (2024-2032) ($MN)
  • Table 5 Global Male Fertility Tracking Market Outlook, By Connected home analyzers (2024-2032) ($MN)
  • Table 6 Global Male Fertility Tracking Market Outlook, By Hormone test kits (2024-2032) ($MN)
  • Table 7 Global Male Fertility Tracking Market Outlook, By Scrotal temperature sensors (2024-2032) ($MN)
  • Table 8 Global Male Fertility Tracking Market Outlook, By Male fertility tracking apps (2024-2032) ($MN)
  • Table 9 Global Male Fertility Tracking Market Outlook, By Accessories & consumables (2024-2032) ($MN)
  • Table 10 Global Male Fertility Tracking Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 11 Global Male Fertility Tracking Market Outlook, By Use Case (2024-2032) ($MN)
  • Table 12 Global Male Fertility Tracking Market Outlook, By Pre-conception screening (2024-2032) ($MN)
  • Table 13 Global Male Fertility Tracking Market Outlook, By Infertility diagnosis & monitoring (2024-2032) ($MN)
  • Table 14 Global Male Fertility Tracking Market Outlook, By Post-vasectomy confirmation (2024-2032) ($MN)
  • Table 15 Global Male Fertility Tracking Market Outlook, By Treatment monitoring (2024-2032) ($MN)
  • Table 16 Global Male Fertility Tracking Market Outlook, By Lifestyle & wellness optimization (2024-2032) ($MN)
  • Table 17 Global Male Fertility Tracking Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 18 Global Male Fertility Tracking Market Outlook, By Online (2024-2032) ($MN)
  • Table 19 Global Male Fertility Tracking Market Outlook, By Offline retail (2024-2032) ($MN)
  • Table 20 Global Male Fertility Tracking Market Outlook, By Clinical procurement (2024-2032) ($MN)
  • Table 21 Global Male Fertility Tracking Market Outlook, By Technology (2024-2032) ($MN)
  • Table 22 Global Male Fertility Tracking Market Outlook, By Lateral flow (2024-2032) ($MN)
  • Table 23 Global Male Fertility Tracking Market Outlook, By Microfluidics (2024-2032) ($MN)
  • Table 24 Global Male Fertility Tracking Market Outlook, By Smartphone optical imaging & computer vision (2024-2032) ($MN)
  • Table 25 Global Male Fertility Tracking Market Outlook, By Electrochemical biosensors (2024-2032) ($MN)
  • Table 26 Global Male Fertility Tracking Market Outlook, By AI/ML-based analytics (2024-2032) ($MN)
  • Table 27 Global Male Fertility Tracking Market Outlook, By End User (2024-2032) ($MN)
  • Table 28 Global Male Fertility Tracking Market Outlook, By Individuals (2024-2032) ($MN)
  • Table 29 Global Male Fertility Tracking Market Outlook, By Fertility clinics & IVF centers (2024-2032) ($MN)
  • Table 30 Global Male Fertility Tracking Market Outlook, By Urology (2024-2032) ($MN)
  • Table 31 Global Male Fertility Tracking Market Outlook, By Telehealth providers (2024-2032) ($MN)
  • Table 32 Global Male Fertility Tracking Market Outlook, By Research & academia (2024-2032) ($MN)
  • Table 33 Global Male Fertility Tracking Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.